Neighborhood matters: Response to EZH2 methyltransferase inhibitors

por Gharpure, Kshipra M, Sood, Anil K
Publicado 2013

Markers of Angiogenesis in Ovarian Cancer

por Merritt, William M., Sood, Anil K.
Publicado 2007

Immunological consequences of ageing microvascular hemodynamic changes in view of cancer development and treatment

por Chung, Jinhyuk Fred, Lee, Sang Joon, Sood, Anil K.
Publicado 2017

Circular RNAs in Cancer

por Bach, Duc-Hiep, Lee, Sang Kook, Sood, Anil K.
Publicado 2019

Editorial: Cardio-Oncology: From Bench to Bedside

por Abe, Jun-ichi, Sood, Anil K., Martin, James F.
Publicado 2019

Human Papillomavirus DNA in LEEP Plume

por Sood, Anil K., Bahrani-Mostafavi, Zahra, Stoerker, Jay, Stone, I. Keith
Publicado 1994

MicroRNA therapeutics: principles, expectations, and challenges

por Rupaimoole, Rajesha, Han, Hee-Dong, Lopez-Berestein, Gabriel, Sood, Anil K.
Publicado 2011

Endothelial cell malignancies: new insights from the laboratory and clinic

por Wagner, Michael J., Ravi, Vinod, Menter, David G., Sood, Anil K.
Publicado 2017

Spatiotemporal view of malignant histogenesis and macroevolution via formation of polyploid giant cancer cells

por Li, Xiaoran, Zhong, Yanping, Zhang, Xudong, Sood, Anil K., Liu, Jinsong
Publicado 2023

Rucaparib in ovarian cancer: an update on safety, efficacy and place in therapy

por Dal Molin, Graziela Z., Omatsu, Kohei, Sood, Anil K., Coleman, Robert L.
Publicado 2018

IL-6 promotes drug resistance through formation of polyploid giant cancer cells and stromal fibroblast reprogramming

por Niu, Na, Yao, Jun, Bast, Robert C., Sood, Anil K., Liu, Jinsong
Publicado 2021

Trends of low-grade serous ovarian carcinoma in the United States

por Matsuo, Koji, Machida, Hiroko, Grubbs, Brendan H., Sood, Anil K., Gershenson, David M.
Publicado 2018

Advances and Challenges of Liposome Assisted Drug Delivery

por Sercombe, Lisa, Veerati, Tejaswi, Moheimani, Fatemeh, Wu, Sherry Y., Sood, Anil K., Hua, Susan
Publicado 2015

microRNA Therapeutics in Cancer — An Emerging Concept

por Shah, Maitri Y., Ferrajoli, Alessandra, Sood, Anil K, Lopez-Berestein, Gabriel, Calin, George A.
Publicado 2016

Emerging Trends in Neoadjuvant Chemotherapy for Ovarian Cancer

por Patel, Ami, Iyer, Puja, Matsuzaki, Shinya, Matsuo, Koji, Sood, Anil K., Fleming, Nicole D.
Publicado 2021

Race-associated Molecular Changes in Gynecologic Malignancies

por Asare, Amma, Yao, Hui, Lara, Olivia D., Wang, Ying, Zhang, Lin, Sood, Anil K.
Publicado 2022

Integrated Analysis of Gene Expression and Tumor Nuclear Image Profiles Associated with Chemotherapy Response in Serous Ovarian Carcinoma

por Liu, Yuexin, Sun, Yan, Broaddus, Russell, Liu, Jinsong, Sood, Anil K., Shmulevich, Ilya, Zhang, Wei
Publicado 2012

miR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma

por GUO, FEI, COGDELL, DAVID, HU, LIMEI, YANG, DA, SOOD, ANIL K., XUE, FENGXIA, ZHANG, WEI
Publicado 2014

Immune cell profiling in cancer: molecular approaches to cell-specific identification

por Lyons, Yasmin A., Wu, Sherry Y., Overwijk, Willem W., Baggerly, Keith A., Sood, Anil K.
Publicado 2017

Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions

por Guo, Fei, Parker Kerrigan, Brittany C, Yang, Da, Hu, Limei, Shmulevich, Ilya, Sood, Anil K, Xue, Fengxia, Zhang, Wei
Publicado 2014